US Stock MarketDetailed Quotes

RDY Dr. Reddy's Laboratories

Watchlist
  • 15.370
  • +0.250+1.65%
Close Dec 20 16:00 ET
  • 15.270
  • -0.100-0.65%
Post 20:01 ET
12.80BMarket Cap20.44P/E (TTM)

Dr. Reddy's Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Total revenue
16.51%80.16B
13.54%279.16B
12.49%70.83B
6.57%72.15B
9.11%68.8B
29.20%67.38B
14.69%245.88B
15.82%62.97B
27.26%67.7B
9.41%63.06B
Operating revenue
16.51%80.16B
13.54%279.16B
12.49%70.83B
6.57%72.15B
9.11%68.8B
29.20%67.38B
14.69%245.88B
15.82%62.97B
27.26%67.7B
9.41%63.06B
Cost of revenue
13.92%32.39B
8.47%115.56B
8.81%29.35B
8.47%29.95B
10.17%28.43B
6.44%27.83B
5.95%106.54B
5.25%26.97B
12.29%27.61B
-3.86%25.81B
Gross profit
18.33%47.77B
17.41%163.61B
15.24%41.48B
5.26%42.2B
8.38%40.37B
52.09%39.55B
22.40%139.34B
25.24%36B
40.13%40.09B
20.99%37.25B
Operating expense
29.90%29.72B
22.43%98.3B
22.96%28.21B
12.28%25.3B
8.94%22.88B
58.57%21.91B
3.04%80.29B
16.38%22.94B
16.40%22.53B
6.08%21.01B
Selling and administrative expenses
22.41%23.01B
13.49%77.2B
13.81%20.48B
12.50%20.23B
13.50%18.8B
14.26%17.7B
9.58%68.03B
14.79%17.99B
16.68%17.98B
3.82%16.56B
Research and development costs
33.49%7.27B
18.02%22.87B
28.16%6.88B
15.43%5.57B
11.87%5.45B
15.24%4.98B
10.86%19.38B
24.04%5.37B
15.92%4.82B
9.10%4.87B
Other operating expenses
59.23%-554M
75.06%-1.78B
302.86%852M
-82.35%-496M
-221.28%-1.36B
87.01%-780M
-333.50%-7.12B
-44.33%-420M
-26.51%-272M
30.88%-423M
Operating profit
3.20%18.05B
10.59%65.31B
1.68%13.28B
-3.74%16.91B
7.66%17.49B
44.75%17.65B
64.41%59.05B
44.55%13.06B
89.73%17.56B
47.86%16.24B
Net non-operating interest income expense
-125.14%-92M
328.63%567M
-55.00%54M
230.34%189M
493.55%366M
703.08%784M
-3,642.86%-248M
-86.03%120M
-408.51%-145M
-3,200.00%-93M
Non-operating interest income
-7.51%665M
93.05%2.28B
36.50%647M
113.55%583M
232.87%719M
----
22.28%1.18B
--474M
4.20%273M
-8.86%216M
Non-operating interest expense
114.45%757M
19.82%1.71B
67.51%593M
-5.74%394M
14.24%353M
----
49.06%1.43B
--354M
94.42%418M
32.05%309M
Total other finance cost
----
----
----
----
----
---784M
----
----
----
----
Other net income (expense)
-5.38%1.21B
284.05%6B
3,431.58%2.68B
208.40%1.16B
3,567.57%1.28B
-98.77%32M
143.03%1.56B
101.03%76M
-364.69%-1.07B
-102.18%-37M
Gain on sale of security
91.73%1.65B
10.51%3.43B
42.56%968M
12,800.00%774M
1,463.49%859M
----
46.83%3.1B
--679M
-97.52%6M
-119.94%-63M
Earnings from equity interest
45.24%61M
-60.27%147M
-53.95%35M
-55.00%27M
-70.00%42M
-54.26%43M
-47.37%370M
-27.62%76M
-67.57%60M
-43.32%140M
Special income (charges)
-229.32%-494M
226.75%2.42B
347.57%1.68B
131.72%361M
435.09%382M
-152.38%-11M
70.36%-1.91B
90.96%-679M
-5,072.73%-1.14B
-110.08%-114M
-Less:Impairment of capital assets
1,580.00%924M
-99.57%3M
-132.04%-173M
-17.91%110M
120.00%55M
--11M
-90.76%699M
-92.81%540M
185.11%134M
--25M
-Less:Other special charges
----
---1.52B
----
----
----
----
----
----
----
----
-Gain on sale of property,plant,equipment
-1.60%430M
174.32%900M
88.49%-16M
146.91%471M
591.01%437M
----
-208.22%-1.21B
---139M
-4,116.00%-1B
-107.87%-89M
Income before tax
0.17%19.17B
19.06%71.87B
20.83%16.02B
11.69%18.26B
18.76%19.13B
25.98%18.46B
86.91%60.37B
433.83%13.26B
68.36%16.35B
27.05%16.11B
Income tax
32.72%5.75B
5.79%16.19B
-19.57%2.95B
15.30%4.47B
-13.02%4.33B
59.70%4.44B
75.26%15.3B
127.80%3.66B
46.56%3.88B
80.48%4.98B
Net income
-9.36%13.42B
23.56%55.68B
36.26%13.07B
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
76.52%12.47B
12.18%11.13B
Net income continuous Operations
-9.36%13.42B
23.56%55.68B
36.26%13.07B
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
76.52%12.47B
12.18%11.13B
Minority interest income
862M
0
Net income attributable to the parent company
-15.18%12.55B
23.56%55.68B
36.26%13.07B
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
76.52%12.47B
12.18%11.13B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-15.18%12.55B
23.56%55.68B
36.26%13.07B
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
76.52%12.47B
12.18%11.13B
Basic earnings per share
-15.29%3.014
23.29%66.93
36.11%15.732
10.28%16.562
-73.61%3.558
17.92%16.8762
91.04%54.286
996.08%11.558
76.35%15.018
12.71%13.48
Diluted earnings per share
-15.26%3.01
23.32%66.804
36.15%15.706
10.31%16.536
-73.45%3.552
17.96%16.844
91.16%54.17
996.58%11.536
76.44%14.99
12.14%13.378
Dividend per share
7.9746
8.0052
0
0
0
8.0052
0
0
0
0
Currency Unit
INR
INR
INR
INR
INR
INR
INR
INR
INR
INR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q2)Sep 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Total revenue 16.51%80.16B13.54%279.16B12.49%70.83B6.57%72.15B9.11%68.8B29.20%67.38B14.69%245.88B15.82%62.97B27.26%67.7B9.41%63.06B
Operating revenue 16.51%80.16B13.54%279.16B12.49%70.83B6.57%72.15B9.11%68.8B29.20%67.38B14.69%245.88B15.82%62.97B27.26%67.7B9.41%63.06B
Cost of revenue 13.92%32.39B8.47%115.56B8.81%29.35B8.47%29.95B10.17%28.43B6.44%27.83B5.95%106.54B5.25%26.97B12.29%27.61B-3.86%25.81B
Gross profit 18.33%47.77B17.41%163.61B15.24%41.48B5.26%42.2B8.38%40.37B52.09%39.55B22.40%139.34B25.24%36B40.13%40.09B20.99%37.25B
Operating expense 29.90%29.72B22.43%98.3B22.96%28.21B12.28%25.3B8.94%22.88B58.57%21.91B3.04%80.29B16.38%22.94B16.40%22.53B6.08%21.01B
Selling and administrative expenses 22.41%23.01B13.49%77.2B13.81%20.48B12.50%20.23B13.50%18.8B14.26%17.7B9.58%68.03B14.79%17.99B16.68%17.98B3.82%16.56B
Research and development costs 33.49%7.27B18.02%22.87B28.16%6.88B15.43%5.57B11.87%5.45B15.24%4.98B10.86%19.38B24.04%5.37B15.92%4.82B9.10%4.87B
Other operating expenses 59.23%-554M75.06%-1.78B302.86%852M-82.35%-496M-221.28%-1.36B87.01%-780M-333.50%-7.12B-44.33%-420M-26.51%-272M30.88%-423M
Operating profit 3.20%18.05B10.59%65.31B1.68%13.28B-3.74%16.91B7.66%17.49B44.75%17.65B64.41%59.05B44.55%13.06B89.73%17.56B47.86%16.24B
Net non-operating interest income expense -125.14%-92M328.63%567M-55.00%54M230.34%189M493.55%366M703.08%784M-3,642.86%-248M-86.03%120M-408.51%-145M-3,200.00%-93M
Non-operating interest income -7.51%665M93.05%2.28B36.50%647M113.55%583M232.87%719M----22.28%1.18B--474M4.20%273M-8.86%216M
Non-operating interest expense 114.45%757M19.82%1.71B67.51%593M-5.74%394M14.24%353M----49.06%1.43B--354M94.42%418M32.05%309M
Total other finance cost -----------------------784M----------------
Other net income (expense) -5.38%1.21B284.05%6B3,431.58%2.68B208.40%1.16B3,567.57%1.28B-98.77%32M143.03%1.56B101.03%76M-364.69%-1.07B-102.18%-37M
Gain on sale of security 91.73%1.65B10.51%3.43B42.56%968M12,800.00%774M1,463.49%859M----46.83%3.1B--679M-97.52%6M-119.94%-63M
Earnings from equity interest 45.24%61M-60.27%147M-53.95%35M-55.00%27M-70.00%42M-54.26%43M-47.37%370M-27.62%76M-67.57%60M-43.32%140M
Special income (charges) -229.32%-494M226.75%2.42B347.57%1.68B131.72%361M435.09%382M-152.38%-11M70.36%-1.91B90.96%-679M-5,072.73%-1.14B-110.08%-114M
-Less:Impairment of capital assets 1,580.00%924M-99.57%3M-132.04%-173M-17.91%110M120.00%55M--11M-90.76%699M-92.81%540M185.11%134M--25M
-Less:Other special charges -------1.52B--------------------------------
-Gain on sale of property,plant,equipment -1.60%430M174.32%900M88.49%-16M146.91%471M591.01%437M-----208.22%-1.21B---139M-4,116.00%-1B-107.87%-89M
Income before tax 0.17%19.17B19.06%71.87B20.83%16.02B11.69%18.26B18.76%19.13B25.98%18.46B86.91%60.37B433.83%13.26B68.36%16.35B27.05%16.11B
Income tax 32.72%5.75B5.79%16.19B-19.57%2.95B15.30%4.47B-13.02%4.33B59.70%4.44B75.26%15.3B127.80%3.66B46.56%3.88B80.48%4.98B
Net income -9.36%13.42B23.56%55.68B36.26%13.07B10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B76.52%12.47B12.18%11.13B
Net income continuous Operations -9.36%13.42B23.56%55.68B36.26%13.07B10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B76.52%12.47B12.18%11.13B
Minority interest income 862M0
Net income attributable to the parent company -15.18%12.55B23.56%55.68B36.26%13.07B10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B76.52%12.47B12.18%11.13B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -15.18%12.55B23.56%55.68B36.26%13.07B10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B76.52%12.47B12.18%11.13B
Basic earnings per share -15.29%3.01423.29%66.9336.11%15.73210.28%16.562-73.61%3.55817.92%16.876291.04%54.286996.08%11.55876.35%15.01812.71%13.48
Diluted earnings per share -15.26%3.0123.32%66.80436.15%15.70610.31%16.536-73.45%3.55217.96%16.84491.16%54.17996.58%11.53676.44%14.9912.14%13.378
Dividend per share 7.97468.00520008.00520000
Currency Unit INRINRINRINRINRINRINRINRINRINR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List

Investment Theme Infectious Disease
Infectious Disease
Intraday+0.78%